SCHEMBL497472

SCHEMBL497472

Nc1ccc(O)cc1Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2520818 0.79
SCHEMBL29032220 0.75 AXL (0.41)
SCHEMBL6582947 0.75 AXL (0.46)
SCHEMBL29617570 0.75
SCHEMBL29458034 0.75
SCHEMBL1047274 0.75
SCHEMBL543834 0.75
SCHEMBL29357630 0.74
SCHEMBL34069 0.74
SCHEMBL4870452 0.74 CYP3A4 (0.61)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117820191-B Diphenylamine compound and preparation method, application and pharmaceutical composition thereof FUDAN UNIVERSITY (CN) 2026-05-26 CN disclosed
CN-119241588-A Sulfonamide compound for treatment and enantiomer thereof, preparation method and application 华创合成制药股份有限公司 2025-01-03 CN disclosed
CN-118930474-A Preparation method of key intermediate of ulcerative colitis treatment drug 北京康立生医药技术开发有限公司 2024-11-12 CN disclosed
CN-118851982-A Preparation method of itramod key intermediate 北京康立生医药技术开发有限公司 2024-10-29 CN disclosed
CN-117820191-A Diphenylamine compound and preparation method, application and pharmaceutical composition thereof 复旦大学 2024-04-05 CN disclosed
US-20200339513-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2020-10-29 US disclosed
US-10800741-B2 Quinoline compound, preparation method and medical use therefor ANCUREALL PHARMACEUTICAL (SHANGHAI) CO., LTD. (CN) 2020-10-13 US disclosed
CN-111527070-A Heterocyclic compound and organic light-emitting device comprising the same LT素材株式会社 2020-08-11 CN disclosed
CN-110049969-A Quinolines, preparation method and its medical usage 恩瑞生物医药科技(上海)有限公司 2019-07-23 CN disclosed
US-8771810-B2 Polymerizable composition, polymer, and film FUJIFILM CORPORATION (JP) 2014-07-08 US disclosed
US-20070254896-A1 SUBSTITUTED PYRIMIDINE KINASE INHIBITORS JANSSEN PHARMACEUTICA, N.V. (BE) 2007-11-01 US disclosed
WO-2007109783-A2 SUBSTITUTED PYRIMIDINE KINASE INHIBITORS JANSSEN PHARMACEUTICA, N.V. (BE) 2007-09-27 WO disclosed
EP-1501352-A4 METHODS AND COMPOSITIONS FOR CONTROLLED RELEASE OF DRUGS UNIV WYOMING (US) 2007-03-07 EP disclosed
EP-1501352-A1 METHODS AND COMPOSITIONS FOR CONTROLLED RELEASE OF DRUGS THE UNIVERSITY OF WYOMING (US) 2005-02-02 EP disclosed
US-20050002895-A1 Methods and compositions for controlled release of drugs WYOMING, UNIVERSITY OF, THE 2005-01-06 US disclosed
US-6613246-B2 Acrylated ester FUJI PHOTO FILM CO., LTD. (JP) 2003-09-02 US disclosed
EP-1134270-B1 Polymerizable liquid crystal compound having amido bond between two cyclic groups FUJI PHOTO FILM CO LTD (JP) 2003-07-23 EP disclosed
WO-2003051113-A1 METHODS AND COMPOSITIONS FOR CONTROLLED RELEASE OF DRUGS THE UNIVERSITY OF WYOMING (US) 2003-06-26 WO disclosed
US-20010035520-A1 Polymerizable liquid crystal compound having amido bond between two cyclic groups FUJIFILM CORPORATION (JP) 2001-11-01 US disclosed
EP-1134270-A1 Polymerizable liquid crystal compound having amido bond between two cyclic groups Fuji Photo Film Co., Ltd. (JP) 2001-09-19 EP disclosed